Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 3

Conditions

Lymphoma 149Lymphoma, Large B-Cell, Diffuse 114Lymphoma, Non-Hodgkin 110Precursor Cell Lymphoblastic Leukemia-Lymphoma 106Leukemia 81Hodgkin Disease 81Small Cell Lung Carcinoma 79Leukemia, Myeloid, Acute 73Burkitt Lymphoma 69Lymphoma, Follicular 67Lymphoma, Mantle-Cell 65Lung Neoplasms 60Lymphoma, Large-Cell, Immunoblastic 54Leukemia, Lymphocytic, Chronic, B-Cell 47Recurrence 40Multiple Myeloma 39Lymphoma, B-Cell, Marginal Zone 36Neuroblastoma 33Congenital Abnormalities 29Carcinoma, Non-Small-Cell Lung 28Lymphoma, B-Cell 25Myelodysplastic Syndromes 24Lymphoma, Large-Cell, Anaplastic 23Lymphoma, Extranodal NK-T-Cell 23Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22Brain Neoplasms 22Sarcoma 21Ovarian Neoplasms 21Lymphoma, T-Cell, Peripheral 20Central Nervous System Neoplasms 20

Interventions

Mitotane 7Cisplatin 6pembrolizumab 5Etoposide 3Doxorubicin 3camrelizumab 2apatinib 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Cytoreduction Surgical Procedures 2sodium thiosulfate 1iodophenyl metomidate 1fludarabine phosphate 1dostarlimab 1cemiplimab 1cabozantinib 1cabazitaxel 1antineoplaston AS 2-1 1antineoplaston A10 1Suramin 1Sunitinib 1Streptozocin 1Sorafenib 1Radiation 1Paclitaxel 1Observation 1Nivolumab 1Megestrol Acetate 1Lymph Node Excision 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Adrenocortical Carcinoma × Etoposide × Clear all
NCT03723941 2024-08-01

ACACIA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 3 Completed
40 enrolled
Endocrine

Adrenocortical Carcinoma

NCT05913427 2024-08-01

PESETA

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Recruiting
80 enrolled
Endocrine

Adrenocortical Carcinoma

NCT00094497 2016-09-21

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

Collaborative Group for Adrenocortical Carcinoma Treatment

Phase 3 Completed
304 enrolled 12 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡